Gender-affirming care may reduce the risk of HIV among trans, nonbinary and gender-diverse people
Gender-affirming hormone therapy (GAHT) is associated with significantly improved HIV outcomes for transgender, nonbinary, ...
Open Access Government12h
Global HIV response: Study warns of setbacks in HIV fight due to funding cuts
A recent study published in The Lancet HIV, conducted by the Burnet Institute and WHO, showed a critical issue regarding ...
News-Medical.Net21h
Gender affirming hormone therapy reduces HIV risk for transgender people
Transgender people receiving gender-affirming hormone therapy have a 37% lower chance of acquiring HIV, and for people living with HIV, hormone therapy appears to offer a 44% lower chance of the virus ...
The Lancet1d
Sudan's war and the burden of HIV: a call for urgent intervention
Sudan has been engulfed in a devastating war that has crippled its health system and displaced millions. The conflict that erupted in April, 2023, between the Sudanese Armed Forces and the ...
HIV-related deaths to reach 2.9M by 2030 reveals study, here's why
The Trump administration, along with Britain and Europe, halted foreign aid that previously supported global HIV initiatives.